TRICARE Pharmacy Program RFI (Draft Section C & H)
Contact and place of performance
Viktoria Reed
USA
The Defense Health Agency (DHA) is in the acquisition planning phase for the next generation TRICARE Pharmacy Program (TPharm6) contract. These draft documents are provided for industry’s feedback and refinement. The Government invites qualified vendors to submit feedback and questions on the following draft documents: Section C, Statement of Work Section H, Special Contract Requirements The DHA will facilitate...
View moreThe Defense Health Agency (DHA) is currently in the acquisition planning phase for the next generation TRICARE Pharmacy Program, designated as TPharm6. This requirement is classified under NAICS 524114 Direct Health and Medical Insurance Carriers and PSC Q201 Medical- General Health Care. The agency, through the TRICARE Management Activity and the Defense Health Agency Aurora office, is seeking industry feedback on draft versions of the Section C Statement of Work and Section H Special Contract Requirements to refine the scope and objectives for the upcoming contract.
Qualified vendors may submit comments and questions regarding these draft documents through May 22, 2026. The government intends to facilitate one-on-one meetings with industry participants during the summer of 2026 to further discuss the requirements and address vendor inquiries. Performance for the TRICARE Pharmacy Program will take place within the United States.
The primary point of contact for this notice is Viktoria Reed. Available documentation includes four attachments: two versions of Section H Special Contract Requirements, a Section C Statement of Work, and a TPharm6 feedback document in spreadsheet format. Submissions must be delivered electronically by the deadline to be considered during this phase of the acquisition planning process.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.